Execution That Money Cannot Buy: Everbright Securities Fined Three Times in a Decade, Repeating the Same Compliance Pitfall

Deep News
Jun 02

This may be the most ironic warning letter in the history of the securities industry.

In 2016, Everbright Securities incurred a massive loss of 5.294 billion yuan due to overseas investments that bypassed headquarters' decision-making and lacked compliance review, nearly crippling the entire company. In response, regulators specifically revised regulations, establishing two ironclad rules for cross-border business: major overseas matters must undergo collective deliberation at headquarters and must have a written review opinion from the compliance officer.

On May 12, 2026, a decade later, the Shanghai Securities Regulatory Bureau issued a warning letter to Everbright Securities: it had committed the exact same error again.

Ironclad Rules Bought at a Cost of 5.2 Billion Yuan, Yet Unenforced After Ten Years

The cost of the MPS incident remains etched in the financial statements of Everbright Securities.

In 2018, net profit attributable to the parent company plummeted from 3.015 billion yuan to 103 million yuan, a year-on-year plunge of 96.57%, and its industry ranking dropped from 10th to 38th place.

From 2018 to 2021, cumulative provisions for estimated liabilities totaled 5.294 billion yuan, equivalent to half of the company's total profits over those five years.

It wasn't until September 2023, with the payment of a 2.64 billion yuan settlement, that the seven-year-long bank litigation was finally concluded.

This risk event, which shocked the entire industry, directly propelled the introduction of the "Measures for the Administration of Securities Companies Establishing, Acquiring, or Taking Equity Stakes in Operating Institutions Overseas." Those two ironclad rules written into the regulations should have been an untouchable red line for all securities firms.

However, judging from regulatory records, Everbright Securities' rectification has always remained on paper.

November 2021: The China Securities Regulatory Commission (CSRC) ordered Everbright Securities to rectify, pointing out the disconnect between domestic and overseas risk control systems, and the inability to uniformly aggregate risk data from platforms such as its Hong Kong subsidiary and Everbright Capital.

June 2022: Another rectification notice was received, as the optimization of 11 overseas subsidiaries and 3 SPV layers was not completed on schedule, and the cleanup of non-financial违规业务 did not meet expectations.

May 2026: The warning letter returned to the starting point: proposals from overseas subsidiaries were not submitted for committee review and lacked written opinions from the compliance officer.

Over a decade, three regulatory reprimands, with the core违规 clauses unchanged.

5.2 billion yuan can buy a painful lesson, but it cannot buy the execution of a system.

The Research Report Chinese Wall: An Industry-Wide Example of "Paper Compliance"

The second违规 point in this warning letter holds even greater significance for the industry: for the first time, regulators skipped over content flaws in individual research reports and directly characterized the issue as "failing to effectively prevent conflicts of interest between research reports and other businesses."

This signifies a fundamental shift in regulatory logic: previously checking if you "wrote it correctly," now checking if you "wrote it cleanly."

Conflicts of interest in securities research are an open secret in the industry: investment banking mandates for IPOs require research report endorsements, institutional commission-sharing relies on research coverage, and proprietary/asset management investments参考 internal conclusions.

The regulatory establishment of the Chinese Wall system was intended to sever this chain of interests, but in practice, it has mostly become a formality.

Since 2026, 17 securities firms have been penalized by regulators for违规 research business practices, with 11 directly cited for "inadequate prevention of conflicts of interest." Everbright Securities being named is not an isolated case, but a集中 exposure of the industry's粗放协同模式.

A clear objective fact needs clarification: it's not that Everbright Securities failed to establish a Chinese Wall system, nor that the compliance department lacks veto power. Rather, in the internal ecosystem of almost all securities firms, when an investment banking project that can generate tens of millions meets a compliance opinion that "might carry risks," it is always compliance that ultimately yields.

The system is written in the manual, but the考核 is刻在骨子里. When the research institute's KPIs are tied to investment banking协同指标 and commission-sharing scale, the independence of research reports is destined to give way to business interests.

Peer Comparison: A Chasm in Control Capability Behind the Scale Gap

We selected two leading firms in cross-border business, CITIC Securities and Guotai Junan Securities, for a横向对比.

CITIC Securities' overseas revenue is approximately 9.25 times that of Everbright Securities, and Guotai Junan's is about 8 times. However, the frequency and severity of违规 at these peers are far lower than at Everbright Securities.

The core gap lies not in business scale, but in organizational structure.

CITIC Securities fully integrates its overseas business into a global unified management system, with all approval authority for major investments and equity changes centralized in the headquarters' Risk Control and Compliance Committee.

Guotai Junan Securities established a three-level管控机制 of "headquarters sets rules, regions抓执行," authorizing routine matters to regions while requiring major-value items to go through committee review.

In contrast, Everbright Securities' overseas business segment has long operated with independent accounting and independent考核. The cost for headquarters to conduct穿透管控 on overseas branches is极高, naturally leading to层层打折 in the implementation of systems.

The Root Cause of Repeated Offenses: A Mechanism Problem, Not an Attitude Problem

Many attribute Everbright Securities' repeated违规 to "not prioritizing compliance." However, the real reason is far more complex.

Inherent Tilt in考核导向

In the operational考核 systems of securities firms, revenue-generating departments like brokerage, investment banking, and investment carry a weight exceeding 80%. Compliance and risk control, as cost centers, are考核仅侧重 on "zero incidents." In terms of resource allocation and departmental influence, business lines naturally hold the advantage.

When a project can bring tens of millions in revenue, while the cost of违规 is merely a warning letter and a deduction of 1 point in the classification rating, any rational manager would choose to "prioritize business advancement."

Rectification Disruption Due to Management Turnover

Over the past decade, Everbright Securities has seen 5 chairmen and 4 presidents, with an average tenure of less than 2 years.

Upon taking office, new management teams invariably优先聚焦 on optimizing current operational indicators. Rectifying cross-border structures and重构内控体系属于中长期投入 projects, with slow results and potential to得罪人, naturally get pushed to the bottom of the priority list.

Past regulatory rectifications have mostly ended with补充文件 and完善流程, never touching the本源 of organizational structure and考核机制. With an iron-clad camp and流水的高管, no one wants to pay for the historical problems of their predecessor.

The Real Impact of This Warning Letter Is Greater Than You Think

Many might think, it's just a warning letter, right? No fines, no business suspension, so what's the big deal?

For a securities firm, the隐性杀伤力 of a warning letter far exceeds that of a fine.

Classification Rating and Increased Regulatory Costs

According to current securities firm classification evaluation rules, this warning letter will be计入 the 2026 evaluation cycle, resulting in a single deduction of 1 point. While it won't cause a major rating downgrade, Everbright Securities has been placed on a regulatory watchlist: on-site inspection frequency in the second half of 2026 will increase by over 50%; the Investor Protection Fund contribution ratio will also rise by 0.5 percentage points, adding approximately 20 million yuan in annual costs.

Pressure on Innovative Business and Institutional Cooperation

Applications for innovative businesses such as establishing new cross-border subsidiaries, expanding overseas derivatives, and cross-border wealth management pilots will face stricter审核, with approval cycles延长 by at least 6 months.

Stable institutional clients like bank wealth management and insurance asset management have incorporated regulatory penalty records into their准入风控清单, potentially suspending new asset management and commission-sharing cooperation.

Industry Demonstration Effect Highlighted

In May of this year, the CSRC联合 eight departments launched a two-year special campaign to整治 illegal cross-border securities business; it also announced a special inspection of securities firms' research business Chinese Wall systems to be conducted in June this year.

Everbright Securities' case has become a参照物 for industry-wide rectification. Subsequently, all securities firms will集中复盘 decision-making processes for overseas subsidiaries and research business考核机制, tightening internal control approval standards from the top down.

Conclusion: The End Goal of Compliance Is Execution

A single warning letter carries no hefty fine, yet it sounds an alarm for the entire securities industry: the era of trading simplified compliance processes for short-term business growth is彻底结束了.

For Everbright Securities, short-term rectification can补全审批流程 and补充合规意见书. But to根治老问题, it must start from the两大底层逻辑 of organizational structure and考核机制.

For the entire industry, compliance is never merely words written in a manual, nor slogans hung on a wall. It is the坚守 in every decision and the执行 in every process.

The end of paper compliance is repeated offenses.

Only when compliance truly becomes a hard考核指标 and a veto item for managers will the sky-high学费 of 5.2 billion yuan not have been paid in vain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10